Diisopropylethylamine → HCID 90203673、化合物
反応式
[CH:1]1([CH2:4][O:5][C:6]2[N:11]=[C:10]([C:12]([OH:14])=O)[CH:9]=[CH:8][C:7]=2[N:15]2[CH2:18][C:17]([F:20])([F:19])[CH2:16]2)[CH2:3][CH2:2]1.[S:21]1[CH2:25][CH:24]([C:26]([NH2:28])=[O:27])[NH:23][CH2:22]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C>CS(C)=O>[CH:1]1([CH2:4][O:5][C:6]2[N:11]=[C:10]([C:12]([N:23]3[CH:24]([C:26]([NH2:28])=[O:27])[CH2:25][S:21][CH2:22]3)=[O:14])[CH:9]=[CH:8][C:7]=2[N:15]2[CH2:18][C:17]([F:20])([F:19])[CH2:16]2)[CH2:2][CH2:3]1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
In analogy to the procedure described in Example 47 b), 6-cyclopropylmethoxy-5-(3,3-difluoro-azetidin-1-yl)-pyridine-2-carboxylic acid (Example 1 b)) was reacted with and 4-thiazolidinecarboxamide (CAN 103749-87-7) in the presence of TBTU and DIEA. The mixture of enantiomers was separated by chiral HPLC (Reprosil Chiral NR). The (−) enantiomer was isolated as white solid; MS (EI): m/e=399.4 [MH+]; αD20 (DMSO)=−547.6°.
後処理
- additionThe mixture of enantiomers
- customwas separated by chiral HPLC (Reprosil Chiral NR)
- customThe (−) enantiomer was isolated as white solid
出典と根拠
- ORDレコード
- ord-0ac6b95bcb5641d3a4f1b1fd101c73b1
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09303012B2
反応ノート
読み込み中…